BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23719262)

  • 21. Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma.
    Yi L; Xiao H; Xu M; Ye X; Hu J; Li F; Li M; Luo C; Yu S; Bian X; Feng H
    J Neuroimmunol; 2011 Mar; 232(1-2):75-82. PubMed ID: 21056915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
    Sung HY; Dowarha D; Chou RH; Yu C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.
    da Fonseca AC; Badie B
    Clin Dev Immunol; 2013; 2013():264124. PubMed ID: 23864876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.
    Sarkar S; Döring A; Zemp FJ; Silva C; Lun X; Wang X; Kelly J; Hader W; Hamilton M; Mercier P; Dunn JF; Kinniburgh D; van Rooijen N; Robbins S; Forsyth P; Cairncross G; Weiss S; Yong VW
    Nat Neurosci; 2014 Jan; 17(1):46-55. PubMed ID: 24316889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.
    Roth W; Isenmann S; Nakamura M; Platten M; Wick W; Kleihues P; Bähr M; Ohgaki H; Ashkenazi A; Weller M
    Cancer Res; 2001 Mar; 61(6):2759-65. PubMed ID: 11289159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of S100B in the interaction between adipocytes and macrophages.
    Fujiya A; Nagasaki H; Seino Y; Okawa T; Kato J; Fukami A; Himeno T; Uenishi E; Tsunekawa S; Kamiya H; Nakamura J; Oiso Y; Hamada Y
    Obesity (Silver Spring); 2014 Feb; 22(2):371-9. PubMed ID: 23804363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAGE ablation attenuates glioma progression and enhances tumor immune responses by suppressing galectin-3 expression.
    Zhang IY; Liu S; Zhang L; Liang R; Fang Q; Zhao J; Ren L; Medina EF; Filippov A; Bonjoc KJ; Chaudhry A; Dayyani M; Bild AH; Badie B
    Neuro Oncol; 2023 May; 25(5):886-898. PubMed ID: 36394567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
    Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages.
    Carvalho da Fonseca AC; Wang H; Fan H; Chen X; Zhang I; Zhang L; Lima FR; Badie B
    J Neuroimmunol; 2014 Sep; 274(1-2):71-7. PubMed ID: 25042352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
    Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
    Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
    Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
    Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired oligodendrogenesis and myelination by elevated S100B levels during neurodevelopment.
    Santos G; Barateiro A; Gomes CM; Brites D; Fernandes A
    Neuropharmacology; 2018 Feb; 129():69-83. PubMed ID: 29126910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
    Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
    J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
    Zhang I; Alizadeh D; Liang J; Zhang L; Gao H; Song Y; Ren H; Ouyang M; Wu X; D'Apuzzo M; Badie B
    PLoS One; 2016; 11(12):e0165118. PubMed ID: 27936099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100B/RAGE/Ceramide signaling pathway is involved in sepsis-associated encephalopathy.
    Zhang L; Jiang Y; Deng S; Mo Y; Huang Y; Li W; Ge C; Ren X; Zhang H; Zhang X; Peng Q; Liu Z; Huang L; Zhou F; Ai Y
    Life Sci; 2021 Jul; 277():119490. PubMed ID: 33862114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The controversial role of microglia in malignant gliomas.
    Wei J; Gabrusiewicz K; Heimberger A
    Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency of S100B confers resistance to experimental diabetes in mice.
    Mohammadzadeh F; Tsoporis JN; Izhar S; Desjardins JF; Parker TG
    Exp Cell Res; 2018 Apr; 365(1):129-137. PubMed ID: 29499206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
    Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
    Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
    [No Abstract]   [Full Text] [Related]  

  • 40. Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.
    Hu F; Dzaye O; Hahn A; Yu Y; Scavetta RJ; Dittmar G; Kaczmarek AK; Dunning KR; Ricciardelli C; Rinnenthal JL; Heppner FL; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    Neuro Oncol; 2015 Feb; 17(2):200-10. PubMed ID: 25452390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.